SPN-817 (BIS-001ER, Huperzine)
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 1
Sponsors and Collaborators
Supernus; Biscayne Phramceuticals, EF, MFF
Mechanism of Action
Acetylcholine
Mechanism Description
inhibits the acetylcholinesterase enzyme
Populations Tested In
Adult Focal Impaired Awareness Seizures
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - NTCG 2006
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link